Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Colonic Neoplasms × Radiation × Clear all

Phase

Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Neoplasms 25 Rectal Neoplasms 18 Prostatic Neoplasms 18 Glioblastoma 16 Breast Neoplasms 16 Squamous Cell Carcinoma of Head and Neck 14 Pancreatic Neoplasms 14 Lung Neoplasms 13 Head and Neck Neoplasms 13 Carcinoma, Non-Small-Cell Lung 12 Neoplasms 10 Neoplasm Metastasis 9 Esophageal Squamous Cell Carcinoma 9 Oropharyngeal Neoplasms 8 Adenocarcinoma Of Esophagus 8 Uterine Cervical Neoplasms 6 Carcinoma, Squamous Cell 6 Urinary Bladder Neoplasms 5 Triple Negative Breast Neoplasms 5 Stomach Neoplasms 5 Gliosarcoma 5 Colorectal Neoplasms 5 Xerostomia 4 Nasopharyngeal Carcinoma 4 Melanoma 4 Glioma 4 Breast Neoplasms, Male 4 Brain Neoplasms 4 Anus Neoplasms 4 Sarcoma 3

Interventions

Fluorouracil 77 Leucovorin 70 Oxaliplatin 69 Irinotecan 67 Bevacizumab 43 Capecitabine 36 Cetuximab 33 Panitumumab 14 Folfox protocol 14 Floxuridine 10 Chemotherapy, Adjuvant 10 Surgical Procedures, Operative 8 Neoadjuvant Therapy 8 IFL protocol 8 Drug Therapy 8 regorafenib 7 pembrolizumab 7 Nivolumab 7 trifluridine tipiracil drug combination 6 XELOX 6 Radiotherapy 6 sargramostim 5 Trastuzumab 5 Melphalan 5 Immunohistochemistry 5 Dexamethasone 5 Celecoxib 5 tislelizumab 4 Trifluridine 4 S 1 (combination) 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01729923 2018-01-16

ADAPT

University of Washington

Phase 2 Terminated

27 enrolled 10 charts

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡